1 / 9

Methylnaltrexone

Methylnaltrexone. Cancer Vaccines. GMK Malignant Melanoma - discontinued. PSMA - Joint Venture with Cytogen Phase 1 prostate cancer vaccine Preclin - antibody and viral vector. HIV Entry Inhibitors. PRO 542 PII(single dose) (n=12) - 60-80% reduction in viral load

aldis
Download Presentation

Methylnaltrexone

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Methylnaltrexone

  2. Cancer Vaccines GMK Malignant Melanoma- discontinued PSMA - Joint Venture with CytogenPhase 1 prostate cancer vaccine Preclin - antibody and viral vector

  3. HIV Entry Inhibitors • PRO 542 • PII(single dose) (n=12) - 60-80% reduction in viral load • PII(multi-dose) - ongoing Preclinical: PRO 140, Provax

  4. Cash  Burn Rate = Quarters Left (22.5 - 2.6)  7.4 ≈ 2.6 Expect Upcoming Financing!

More Related